Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | CALL | $65.00 | 2,745 | +96 | +3.62% |
| 02/20/2026 | CALL | $70.00 | 418 | +41 | +10.88% |
| 04/17/2026 | CALL | $80.00 | 104 | +33 | +46.48% |
| 04/17/2026 | PUT | $55.00 | 767 | +28 | +3.79% |
| 07/17/2026 | CALL | $60.00 | 129 | +12 | +10.26% |
| 04/17/2026 | CALL | $65.00 | 785 | +11 | +1.42% |
| 01/21/2028 | PUT | $100.00 | 221 | 0 | |
| 02/20/2026 | CALL | $90.00 | 673 | -1 | -0.15% |
| 04/17/2026 | PUT | $50.00 | 399 | -1 | -0.25% |
| 05/15/2026 | CALL | $65.00 | 707 | -1 | -0.14% |
| 07/17/2026 | CALL | $65.00 | 152 | -1 | -0.65% |
| 03/20/2026 | CALL | $75.00 | 396 | -7 | -1.74% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| iShares Core S&P Smallcap ETF | 7.49% | 7.16M | 252.72M |
| Vanguard Total Stock Market Index Fund | 2.85% | 2.73M | 96.31M |
| Vanguard Small-Cap Index Fund | 2.42% | 2.32M | 81.73M |
| Vanguard Specialized-Health Care Fund | 2.39% | 2.28M | 80.53M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.02% | 1.93M | 68.06M |
| Fidelity Select Portfolios - Biotechnology | 2.01% | 1.92M | 67.85M |
| iShares Russell 2000 ETF | 1.89% | 1.81M | 63.74M |
| Fidelity Select Portfolios - Health Care | 1.57% | 1.5M | 52.94M |
| Lord Abbett Securities Trust-Growth Leaders Fund | 1.42% | 1.36M | 48.07M |
| Vanguard Small-Cap Growth Index Fund | 1.40% | 1.34M | 47.22M |
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/20 05:00 pm
GlobeNewswire Inc.
Read moreCytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference
01/05 05:00 pm
GlobeNewswire Inc.
Read moreTango Therapeutics Appoints Sung Lee to Board of Directors
01/05 08:00 am
GlobeNewswire Inc.
Read moreCytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms
12/19 05:00 pm
GlobeNewswire Inc.
Read moreCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
12/16 05:00 pm
GlobeNewswire Inc.
Read moreChronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
11/25 02:00 pm
GlobeNewswire Inc.
Read moreCYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
11/16 01:00 pm
GlobeNewswire Inc.
Read moreCYTK DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK
11/15 08:52 pm
GlobeNewswire Inc.
Read moreaTyr Pharma, Inc. Class Action: Levi & Korsinsky Reminds aTyr Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – ATYR
11/14 05:00 pm
GlobeNewswire Inc.
Read moreCYTK LAWSUIT ALERT: Levi & Korsinsky Notifies Cytokinetics, Incorporated Investors of a Class Action Lawsuit and Upcoming Deadline
11/14 05:00 pm
GlobeNewswire Inc.
Read moreCYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
11/12 01:00 pm
GlobeNewswire Inc.
Read moreROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK
11/09 11:56 pm
GlobeNewswire Inc.
Read moreROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK
11/05 09:15 pm
GlobeNewswire Inc.
Read moreCytokinetics Reports Third Quarter 2025 Financial Results and Provides Business Update
11/05 05:00 pm
GlobeNewswire Inc.
Read moreROSEN, A LEADING AND RANKED FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/31 03:42 pm
GlobeNewswire Inc.
Read moreROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/28 01:49 pm
GlobeNewswire Inc.
Read moreCYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
10/28 10:00 am
GlobeNewswire Inc.
Read moreCYTOKINETICS CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Cytokinetics Investors of the Filed Class Action Lawsuit and Urges Investors to Contact the Firm Before November 17th
10/25 10:50 am
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
10/24 10:00 am
GlobeNewswire Inc.
Read moreROSEN, NATIONAL TRIAL COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/22 09:32 pm
GlobeNewswire Inc.
Read moreCYTK Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Cytokinetics, Inc. Class Action
10/22 08:48 pm
GlobeNewswire Inc.
Read moreCytokinetics to Announce Third Quarter Results on November 5, 2025
10/22 04:00 pm
GlobeNewswire Inc.
Read moreCYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cytokinetics, Incorporated and Encourages Investors to Contact the Firm
10/21 05:44 pm
GlobeNewswire Inc.
Read moreINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK
10/20 12:43 pm
GlobeNewswire Inc.
Read moreROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/19 07:32 pm
GlobeNewswire Inc.
Read moreROSEN, A LEADING LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/16 10:22 pm
GlobeNewswire Inc.
Read moreROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CPTN
10/16 10:10 pm
GlobeNewswire Inc.
Read moreClass Action Filed Against Cytokinetics, Incorporated (CYTK) - November 17, 2025 Deadline to Join – Contact The Gross Law Firm
10/16 04:00 pm
GlobeNewswire Inc.
Read moreCYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
10/16 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, NATIONAL TRIAL LAWYERS, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CYTK
10/13 07:47 pm
GlobeNewswire Inc.
Read moreClass Action Filed Against Cytokinetics, Incorporated (CYTK) Seeking Recovery for Investors – Contact The Gross Law Firm
10/13 04:00 pm
GlobeNewswire Inc.
Read moreCYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
10/12 08:26 am
GlobeNewswire Inc.
Read moreBragar Eagel & Squire, P.C. Reminds Investors of VFC, Cytokinetics, Quanex, and RCI to Contact the Firm About their Rights in Filed Class Action Lawsuits
10/11 11:32 am
GlobeNewswire Inc.
Read moreCYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
10/09 12:00 pm
GlobeNewswire Inc.
Read more